|
|
The mechanism of FPR2 in suppressing the proliferation, migration and invasion of human extravillous trophoblastic cells |
Zhao Shenzhi1, HUANG Xianping2, XIANG Huiqiu2, LIAO Tingting2, CHEN Jiajia2, XU Zhangye2 |
1.The Second Clinical Medical of Wenzhou Medical University, Wenzhou, 325035; 2.Department of Gynecology and Obstetrics, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027 |
|
Cite this article: |
Zhao Shenzhi,HUANG Xianping,XIANG Huiqiu, et al. The mechanism of FPR2 in suppressing the proliferation, migration and invasion of human extravillous trophoblastic cells[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2018, 48(8): 552-556.
|
|
Abstract Objective: To explore the preliminary mechanism and effect of FPR2 on the proliferation, migration and invasion of human extravillous trophoblastic cells (TEV-1). Methods: Overexpression of FPR2 RNA was constructed and transfected into human TEV-1 cells. MTT assay, transwell assay and scarification test were used to detect the cell proliferation, migration and invasion. RT-PCR and Western blot was used to detect the expression of NF-ĸB and MMP9 mRNA and protein. Results: Over-expression of FPR2 significantly increased the expression levels of FPR2 mRNA and protein in TEV-1 cells (P<0.001), indicating that the transfection was successful. Over-expression of FPR2 gene significantly inhibited the proliferation, invasion (P<0.01) and migration of TEV-1 cells (P<0.05). Over-expression of FPR2 gene significantly decreased the mRNA and protein levels of NF-ĸB and MMP9 in TEV-1 cells (P<0.001). Conclusion: These findings indicated that over-expression of FPR2 gene may perturb proliferation, migration and invasion through NF-ĸB/MMP9 pathway in TEV-1 cells.
|
|
|
|
|
|
[1] SIMPSON W, STEINER M, COOTE M, et al. Relationship between inflammatory biomarkers and depressive symptoms during late pregnancy and the early postpartum period: a longitudinal study[J]. Rev Bras Psiquiatr, 2016, 38(3): 190-196.
[2] KALAGIRI R R, CARDER T, CHOUDHURY S, et al. Inflammation in complicated pregnancy and its outcome[J]. Am J Perinatol, 2016, 33(14): 1337-1356.
[3] BRADY H R, SERHAN C N. Lipoxins: putative braking signals in host defense, inflammation and hypersensitivity[J]. Curr Opin Nephrol Hypertens, 1996, 5(1): 20-27.
[4] LIN F, ZENG P, XU Z, et al. Treatment of Lipoxin A(4) and its analogue on low-dose endotoxin induced preeclampsia in rat and possible mechanisms[J]. Reprod Toxicol, 2012, 34 (4): 677-685.
[5] XU Z, ZHAO J, ZHANG H, et al. Spontaneous miscarriages are explained by the stress/glucocorticoid/lipoxin A4 axis[J]. J Immunol, 2013, 190(12): 6051-6058.
[6] XU Z, ZHAO F, XIANG H, et al. Lipoxin A4: The double-edge sword in mice pregnancy[J]. Am J Reprod Immunol, 2014, 72(1): 57-64.
[7] GUPTA S K, MALHOTRA S S, MALIK A, et al. Cell signaling pathways involved during invasion and syncytialization of trophoblast cells[J]. Am J Reprod Immunol, 2016, 75(3): 361-371.
[8] YE R D, BOULAY F, WANG J M, et al. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family[J]. Pharmacol Rev, 2009, 61(2): 119-161.
[9] STEPNIEWSKI T M, FILIPEK S. Non-peptide ligand binding to the formyl peptide receptor FPR2--A comparison to peptide ligand binding modes[J]. Bioorg Med Chem, 2015, 23(14): 4072-4081.
[10] MADOGLIO R J, RUGOLO L M, KUROKAWA C S, et al. Inflammatory and oxidative stress airway markers in premature newborns of hypertensive mothers[J]. Braz J Med Biol Res, 2016, 49(9): e5160.
[11] XIA Y, KELLEMS R E. Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond[J]. Circ Res, 2013, 113(1): 78-87.
[12] MACDONALD L J, BODDY S C, DENISON F C, et al. A role for lipoxin A4 as an anti-inflammatory mediator in the human endometrium[J]. Reproduction, 2011, 142(2): 345-352.
[13] DONG W, YIN L. Expression of lipoxin A4, TNFα and IL-1β in maternal peripheral blood, umbilical cord blood and placenta, and their significance in pre-eclampsia[J]. Hypertens Pregnancy, 2014, 33(4): 449-456.
[14] BAUD V, KARIN M. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls[J]. Nat Rev Drug Discov, 2009, 8(1): 33-40.
[15] MARCHAND M, HORCAJADAS J A, ESTEBAN F J, et al.
Transcriptomic signature of trophoblast differentiation in a human embryonic stem cell model[J]. Biol Reprod, 2011, 84(6): 1258-1271.
[16] ROSS J W, ASHWORTH M D, MATHEW D, et al. Activation of the transcription factor, nuclear factor kappa-B, during the estrous cycle and early pregnancy in the pig[J]. Reprod Biol Endocrinol, 2010, 8: 39.
[17] DI S N, DI N F, D’IPPOLITO S, et al. Antiphospholipid antibodies affect human endometrial angiogenesis[J]. Biol Reprod, 2010, 83(2): 212-219.
[18] 林燕燕, 廖婷婷, 金佳希, 等. 基因沉默整合素连接激酶对滋养细胞生物学功能的影响[J]. 温州医科大学学报, 2018, 48(3): 168-171, 177. |
|
|
|